US to pay Sanofi, GlaxoSmithKline up to $2.1B for development, 100M doses of coronavirus vaccine

(By Katie Adams for Becker’s Hospital Review)

The U.S. government signed a contract July 31 with Sanofi and GlaxoSmithKline to pay up to $2.1 billion for the development and supply of a COVID-19 vaccine.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or


Leave a Reply